CURTIS JASON TRAVIS 4
4 · U S PHYSICAL THERAPY INC /NV · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
U S PHYSICAL THERAPY (USPH) Interim CFO Jason Travis Surrenders 40 Shares
What Happened Jason Travis, Interim Chief Financial Officer of U S PHYSICAL THERAPY (USPH), surrendered 40 shares of common stock on May 20, 2026 to satisfy tax withholding obligations related to a vesting event. The shares were valued at $62.24 each, for a total of $2,490. This was a tax-withholding disposition (transaction code F), not an open-market sale.
Key Details
- Transaction date and price: May 20, 2026 — 40 shares at $62.24 each (total $2,490).
- Transaction type: Code F — shares surrendered to issuer to satisfy tax withholding on vested restricted stock.
- Restricted shares noted: Footnote reports 3,596 shares subject to vesting under the Company’s Amended and Restated 2003 Stock Incentive Plan, with detailed future vesting dates through March 6, 2030.
- Shares owned after transaction: Form lists the restricted shares subject to vesting (3,596); the filing does not disclose a separate total beneficial ownership number beyond the restricted grant details.
- Filing timeliness: This Form 4 was filed late; the filing (dated June 22, 2026) states the delay was due to an inadvertent administrative error (timeliness = L).
Context This was a routine tax-withholding surrender associated with restricted stock vesting, not a discretionary sale that would indicate trading sentiment. For clarity: code F transactions are standard when insiders remit shares to the company to cover taxes upon vesting. The filing’s late submission is disclosed but the transaction itself is administrative.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-05-20$62.24/sh−40$2,490→ 3,893 total
Footnotes (2)
- [F1]The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
- [F2]Includes 3,596 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 171 shares vest on each of August 20, 2026, November 20, 2026, and March 6, 2027; 1,250 shares vest on May 15, 2027; 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029; 178 shares vest on May 20, 2029; 93 shares vest on each of August 20, 2029 and November 20, 2029; and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date.